National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Conference Call Meeting

---
identifier: "/us/fr/03-142"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Conference Call Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "03-142"
section_name: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Conference Call Meeting"
positive_law: false
currency: "2003-01-06"
last_updated: "2003-01-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-142"
document_type: "notice"
publication_date: "2003-01-06"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 565"
fr_volume: 68
---


#  National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Conference Call Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee conference call meeting.

*Name:* National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).

*Time and Date:* 1 p.m.-4 p.m., January 23, 2003.

*Place:* The conference call will originate at the National Center on Birth Defects and Developmental Disabilities (NCBDDD), in Atlanta, Georgia. Please see *Supplementary Information* for details on accessing the conference call.

*Status:* Open to the public, limited only by the availability of telephone ports.

*Purpose:* The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Pub. L. 105-392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE.

*Matters To Be Discussed:* The Task Force will convene by conference call to: (1) Discuss and deliberate a request to endorse recommendations on FAS prevention by the Teratology Society; (2) further discuss activities proposed by the Center for Science in the Public Interest on issues regarding the labeling of alcohol beverages by the Bureau of Alcohol, Tobacco, and Firearms; and (3) discuss progress on a letter to the Surgeon General's Office requesting that he reissue the Federal Advisory against drinking during pregnancy. Agenda items are subject to change as priorities dictate.

**SUPPLEMENTARY INFORMATION:**

This conference call is scheduled to begin at 1 p.m., Eastern Standard Time. To participate in the conference call, please dial 1-800-713-1971 and enter conference code 908417. You will then be automatically connected to the call.

*Contact Person for More Information:* R. Louise Floyd, DSN, RN, Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

Dated: December 30, 2002.

Joseph E. Salter,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).